Filing Details
BOSTON SCIENTIFIC CORP (NYSE:BSX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 03, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNYSE:BSX
BOSTON SCIENTIFIC CORP (BSX) Files Quarterly Report for Q0
Filing Details BOSTON SCIENTIFIC CORP (NYSE:BSX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 03, 2026. The Healthcare company…
Market Context
BOSTON SCIENTIFIC CORP's stock currently trades at $48.43 with a market capitalization of $136.0B.
The 10-Q provides BOSTON SCIENTIFIC CORP's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for BOSTON SCIENTIFIC CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BSX Stock Page
Frequently Asked Questions
Where can I read BSX's SEC filings?
Browse all filings on our BSX SEC filings page.
What types of SEC filings does BOSTON SCIENTIFIC CORP file?
Public companies like BOSTON SCIENTIFIC CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
